JP2022536469A5 - - Google Patents
Info
- Publication number
- JP2022536469A5 JP2022536469A5 JP2021571690A JP2021571690A JP2022536469A5 JP 2022536469 A5 JP2022536469 A5 JP 2022536469A5 JP 2021571690 A JP2021571690 A JP 2021571690A JP 2021571690 A JP2021571690 A JP 2021571690A JP 2022536469 A5 JP2022536469 A5 JP 2022536469A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962860146P | 2019-06-11 | 2019-06-11 | |
| US62/860,146 | 2019-06-11 | ||
| PCT/US2020/037008 WO2020252029A1 (en) | 2019-06-11 | 2020-06-10 | Anti-pcrv antibodies that bind pcrv, compositions comprising anti-pcrv antibodies, and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022536469A JP2022536469A (ja) | 2022-08-17 |
| JP2022536469A5 true JP2022536469A5 (https=) | 2023-06-13 |
Family
ID=71948699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571690A Ceased JP2022536469A (ja) | 2019-06-11 | 2020-06-10 | ＰｃｒＶに結合する抗ＰｃｒＶ抗体、抗ＰｃｒＶ抗体を含む組成物、およびその使用方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11655286B2 (https=) |
| EP (1) | EP3983015A1 (https=) |
| JP (1) | JP2022536469A (https=) |
| KR (1) | KR20220019755A (https=) |
| CN (1) | CN113966343A (https=) |
| AU (1) | AU2020292283A1 (https=) |
| BR (1) | BR112021023335A2 (https=) |
| CA (1) | CA3140075A1 (https=) |
| CL (4) | CL2021003215A1 (https=) |
| CO (1) | CO2021015254A2 (https=) |
| EA (1) | EA202192810A1 (https=) |
| IL (1) | IL288727A (https=) |
| MA (2) | MA56205A (https=) |
| MX (1) | MX2021015156A (https=) |
| PH (1) | PH12021552903A1 (https=) |
| SG (1) | SG11202112462RA (https=) |
| WO (1) | WO2020252029A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20201370T1 (hr) | 2011-11-07 | 2020-11-27 | Medimmune Limited | Kombinacijske terapije koje koriste anti-pseudomonas psl i pcrv vezujuće molekule |
| FR3114970B1 (fr) | 2020-10-08 | 2023-06-30 | Univ Tours | Combinaison d’anticorps inhalés avec des agents immunomodulateurs pour le traitement ou la prévention d’inféctions respiratoires |
| CN114404614B (zh) * | 2022-01-28 | 2024-04-23 | 上海交通大学 | 一种靶向铜绿假单胞菌的免疫脂质体及其制备方法和应用 |
| CN117222740A (zh) * | 2022-06-07 | 2023-12-12 | 南方科技大学 | 编码PcrV和/或OprF-I蛋白的mRNA疫苗 |
| WO2024206669A2 (en) * | 2023-03-29 | 2024-10-03 | Virtuoso Binco, Inc. | Antibodies for targeting cd47 and b7h3 and methods of use thereof |
| AU2024307442A1 (en) | 2023-06-28 | 2026-02-19 | Universität Zu Köln | Neutralizing human monoclonal antibodies against p. aeruginosa |
| CN118440191B (zh) * | 2024-05-11 | 2025-06-10 | 重庆原伦生物科技有限公司 | 一种抗铜绿假单胞菌PcrV抗体的制备及其应用 |
| CN118530352B (zh) * | 2024-05-11 | 2025-03-25 | 重庆原伦生物科技有限公司 | 一种特异性识别铜绿假单胞菌PcrV的抗体及其应用 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5932448A (en) | 1991-11-29 | 1999-08-03 | Protein Design Labs., Inc. | Bispecific antibody heterodimers |
| US6129914A (en) | 1992-03-27 | 2000-10-10 | Protein Design Labs, Inc. | Bispecific antibody effective to treat B-cell lymphoma and cell line |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US5532210A (en) | 1994-06-08 | 1996-07-02 | E. I. Du Pont De Nemours And Company | High temperature superconductor dielectric slow wave structures for accelerators and traveling wave tubes |
| GB9818110D0 (en) | 1998-08-19 | 1998-10-14 | Weston Medical Ltd | Needleless injectors and other devices |
| US6096002A (en) | 1998-11-18 | 2000-08-01 | Bioject, Inc. | NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method |
| HK1044159A1 (zh) | 1998-12-01 | 2002-10-11 | 蛋白质设计实验室股份有限公司 | 抗γ-干扰素的人化抗体 |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| WO2002064161A2 (en) | 2001-01-26 | 2002-08-22 | Mcw Research Foundation, Inc. | Method and compositions for immunization with the pseudomonas v antigen |
| US20040101920A1 (en) | 2002-11-01 | 2004-05-27 | Czeslaw Radziejewski | Modification assisted profiling (MAP) methodology |
| US7850962B2 (en) | 2004-04-20 | 2010-12-14 | Genmab A/S | Human monoclonal antibodies against CD20 |
| ES2463476T3 (es) | 2004-10-19 | 2014-05-28 | Regeneron Pharmaceuticals, Inc. | Método para generar un ratón homocigótico para una modificación genética |
| US8257740B1 (en) | 2011-08-15 | 2012-09-04 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
| US8246995B2 (en) | 2005-05-10 | 2012-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells |
| JP5307708B2 (ja) | 2006-06-02 | 2013-10-02 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒトｉｌ−６受容体に対する高親和性抗体 |
| BRPI0819598A2 (pt) * | 2007-11-30 | 2017-05-09 | Kalobios Pharmaceuticals Inc | anticorpos para o antígeno pcrv da pseudomonas aeruginosa |
| EA020544B1 (ru) | 2008-01-10 | 2014-12-30 | Шионоги Энд Ко., Лтд. | АНТИТЕЛА ПРОТИВ PcrV |
| BRPI0906945A2 (pt) | 2008-01-11 | 2015-07-14 | Lilly Co Eli | (e)-n-{3-[1-(8-flúor-11h-10-oxa-1-aza-dibenzo[a,d]ciclo-h epten-5-ilideno)-propil]-fenil}-metinsulfona amida como modulador de receptores de glicocorticoides para o tratamento de reumatoide. |
| SG174225A1 (en) * | 2009-03-11 | 2011-10-28 | Shionogi & Co | Humanized pcrv antibody having anti-pseudomonal activity |
| MY192182A (en) | 2009-06-26 | 2022-08-04 | Regeneron Pharma | Readily isolated bispecific antibodies with native immunoglobulin format |
| WO2012122533A2 (en) | 2011-03-10 | 2012-09-13 | The University Of Chicago | Compositions and methods related to antibodies to staphylococcal proteins isda or isdb |
| SMT202600080T1 (it) | 2010-02-08 | 2026-03-09 | Regeneron Pharma | Topo con catena leggera comune |
| HRP20201370T1 (hr) * | 2011-11-07 | 2020-11-27 | Medimmune Limited | Kombinacijske terapije koje koriste anti-pseudomonas psl i pcrv vezujuće molekule |
| WO2013096948A1 (en) | 2011-12-23 | 2013-06-27 | Lydon Nicholas B | Immunoglobulins and variants directed against pathogenic microbes |
| BR112015010240A2 (pt) * | 2012-11-06 | 2017-08-22 | Medimmune Ltd | Terapias de combinação através do uso de mo-léculas de ligação de psl e de pcrv anti-pseudomonas |
| TWI635098B (zh) | 2013-02-01 | 2018-09-11 | 再生元醫藥公司 | 含嵌合恆定區之抗體 |
| TWI719938B (zh) * | 2014-06-19 | 2021-03-01 | 美商麥迪紐有限責任公司 | 多重細菌感染之治療 |
| AR101262A1 (es) | 2014-07-26 | 2016-12-07 | Regeneron Pharma | Plataforma de purificación para anticuerpos biespecíficos |
| WO2017095744A1 (en) * | 2015-11-30 | 2017-06-08 | Medimmune, Llc | Method for preventing or treating nosocomial pneumonia |
| GB201602156D0 (en) | 2016-02-05 | 2016-03-23 | Jones Philip C And Boku University Of Natural Resources And Life Sciences | Heterodimers and purification thereof |
| TWI781130B (zh) | 2017-01-03 | 2022-10-21 | 美商再生元醫藥公司 | 抗金黃色葡萄球菌溶血素ａ毒素之人類抗體 |
| CA3076632A1 (en) | 2017-09-29 | 2019-04-04 | Regeneron Pharmaceuticals, Inc. | Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereof |
-
2020
- 2020-06-10 EP EP20751363.1A patent/EP3983015A1/en not_active Withdrawn
- 2020-06-10 US US16/898,193 patent/US11655286B2/en active Active
- 2020-06-10 MX MX2021015156A patent/MX2021015156A/es unknown
- 2020-06-10 WO PCT/US2020/037008 patent/WO2020252029A1/en not_active Ceased
- 2020-06-10 CN CN202080042874.7A patent/CN113966343A/zh active Pending
- 2020-06-10 CA CA3140075A patent/CA3140075A1/en active Pending
- 2020-06-10 EA EA202192810A patent/EA202192810A1/ru unknown
- 2020-06-10 SG SG11202112462RA patent/SG11202112462RA/en unknown
- 2020-06-10 JP JP2021571690A patent/JP2022536469A/ja not_active Ceased
- 2020-06-10 MA MA056205A patent/MA56205A/fr unknown
- 2020-06-10 AU AU2020292283A patent/AU2020292283A1/en not_active Abandoned
- 2020-06-10 MA MA54975A patent/MA54975B1/fr unknown
- 2020-06-10 KR KR1020227000136A patent/KR20220019755A/ko not_active Withdrawn
- 2020-06-10 BR BR112021023335A patent/BR112021023335A2/pt unknown
- 2020-06-10 PH PH1/2021/552903A patent/PH12021552903A1/en unknown
-
2021
- 2021-11-11 CO CONC2021/0015254A patent/CO2021015254A2/es unknown
- 2021-12-03 CL CL2021003215A patent/CL2021003215A1/es unknown
- 2021-12-06 IL IL288727A patent/IL288727A/en unknown
-
2023
- 2023-04-19 US US18/303,453 patent/US12552856B2/en active Active
- 2023-12-11 CL CL2023003695A patent/CL2023003695A1/es unknown
- 2023-12-11 CL CL2023003696A patent/CL2023003696A1/es unknown
- 2023-12-11 CL CL2023003694A patent/CL2023003694A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022536469A5 (https=) | ||
| JP2018512435A5 (https=) | ||
| JP2023515271A5 (https=) | ||
| JP2021063090A5 (https=) | ||
| JP2023052458A5 (https=) | ||
| JP2025172841A5 (https=) | ||
| JP2020528768A5 (https=) | ||
| RU2016130056A (ru) | Способы лечения кожной инфекции путем введения антагониста il-4r | |
| JP2021519295A5 (https=) | ||
| JP2021523188A5 (https=) | ||
| JP2024174962A5 (https=) | ||
| RU2013155906A (ru) | Антитела анти-angptl3 и их применение | |
| JP2021527640A5 (https=) | ||
| JP2024531151A5 (https=) | ||
| JP2017519768A5 (https=) | ||
| JP2023089191A5 (https=) | ||
| JP2019534003A5 (https=) | ||
| JP2023545520A5 (https=) | ||
| JP2022512647A5 (https=) | ||
| JP2022523372A5 (https=) | ||
| JP2021510523A5 (https=) | ||
| JP2022523530A5 (https=) | ||
| JP2024516698A5 (https=) | ||
| JP2024540226A5 (https=) | ||
| JP2022512904A5 (https=) |